Stock Research for ABBV

ABBV

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

ABBV Stock Chart & Research Data

The ABBV chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ABBV chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ABBV Due diligence Resources & Stock Charts

The ABBV stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ABBV Detailed Price Forecast - CNN Money CNN View ABBV Detailed Summary - Google Finance
Yahoo View ABBV Detailed Summary - Yahoo! Finance Zacks View ABBV Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View ABBV Trends & Analysis - Trade-Ideas Barrons View ABBV Major Holders - Barrons
NASDAQ View ABBV Call Transcripts - NASDAQ Seeking View ABBV Breaking News & Analysis - Seeking Alpha
Spotlight View ABBV Annual Report - CompanySpotlight.com OTC Report View ABBV OTC Short Report - OTCShortReport.com
TradeKing View ABBV Fundamentals - TradeKing Charts View ABBV SEC Filings - Bar Chart
WSJ View Historical Prices for ABBV - The WSJ Morningstar View Performance/Total Return for ABBV - Morningstar
MarketWatch View the Analyst Estimates for ABBV - MarketWatch CNBC View the Earnings History for ABBV - CNBC
StockMarketWatch View the ABBV Earnings - StockMarketWatch MacroAxis View ABBV Buy or Sell Recommendations - MacroAxis
Bullish View the ABBV Bullish Patterns - American Bulls Short Pains View ABBV Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View ABBV Stock Mentions - StockTwits PennyStocks View ABBV Stock Mentions - PennyStockTweets
Twitter View ABBV Stock Mentions - Twitter Invest Hub View ABBV Investment Forum News - Investor Hub
Yahoo View ABBV Stock Mentions - Yahoo! Message Board Seeking Alpha View ABBV Stock Mentions - Seeking Alpha






Financial & Transaction Holdings

SECform4 View Insider Transactions for ABBV - SECform4.com Insider Cow View Insider Transactions for ABBV - Insider Cow
CNBC View ABBV Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ABBV - OTC Markets
Yahoo View Insider Transactions for ABBV - Yahoo! Finance NASDAQ View Institutional Holdings for ABBV - NASDAQ


Stock Charts

FinViz View ABBV Stock Insight & Charts - FinViz.com StockCharts View ABBV Investment Charts - StockCharts.com
BarChart View ABBV Stock Overview & Charts - BarChart Trading View View ABBV User Generated Charts - Trading View


Latest Financial News for ABBV

Bristol-Myers Posts Data on Empliciti, China Approves Opdivo
Posted on Monday June 18, 2018

Bristol-Myers (BMY) announces positive results on oncology drug Empliciti. The company's blockbuster drug, Opdivo, was also approved in China for lung cancer.


How U.S. tax reform rewards companies that shift profit to tax havens
Posted on Monday June 18, 2018

The new tax bill cuts the overall corporate tax rate to 21 percent, and allows income from overseas to be taxed at about half that rate – to as low as 10 percent. AbbVie Inc. (ABBV.N) is a case in point. Its Chief Executive Richard Gonzalez told investors earlier this year that because of the change to a territorial system, whereby only profits reported by domestic subsidiaries face U.S. tax, the U.S. drugmaker expects its tax rate to fall to 9 percent this year from around 22 percent in recent years.


Today's Research Reports on Trending Tickers: Canopy Growth and AbbVie
Posted on Monday June 18, 2018

NEW YORK, NY / ACCESSWIRE / June 18, 2018 / U.S. market plunged on Friday, but well-off session lows as investors appeared to look at previous signs of escalating trade tension between Washington and Beijing. ...


Big Pharma Stock Investors Beware: Another $250 Billion Patent Cliff Is Coming
Posted on Sunday June 17, 2018

Several big pharma companies are about to lose patent exclusivity for blockbuster drugs. Should investors be worried?


Enter a stock symbol to view the stock details.